ArticleCanadian pharmacists journal : CPJ = Revue des pharmaciens du Canada : RPC2016
Community pharmacist targeted screening for chronic kidney disease.
Article in Canadian pharmacists journal : CPJ = Revue des pharmaciens du Canada : RPC, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 20 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
20 citing papers in PubMed.
- Cytopenias as Adverse Drug Reactions: A 10-Year Analysis of Reporting Structure, Rate, and Trend.Pharmaceuticals (Basel, Switzerland) · 2025Article
- Evaluation of an educational program for community pharmacists involved in pharmacotherapy for patients with impaired renal function: a preliminary study.Clinical and experimental nephrology · 2025Article
- Risk Factor-Based Screening for Early Detection of Chronic Kidney Disease in Primary Care Settings: A Systematic Review.Kidney medicine · 2025Article
- Early Detection of Chronic Kidney Disease in Mexico, a Case for Policy Transfer.Risk management and healthcare policy · 2025Article
- Exploring the Role of Clinical Pharmacists in the Correctional Health Care Setting: A Narrative Review.The Canadian journal of hospital pharmacy · 2025Review
- Article
- [Screening for Chronic Kidney Disease in the Community Pharmacy. CRIERFAC Study: Description of the Methodology].Farmaceuticos comunitarios · 2024Article
- Community pharmacist-led point-of-care eGFR screening: early detection of chronic kidney disease in high-risk patients.Scientific reports · 2024Article
- Optimizing Collaborative Care of Patients with Chronic Kidney Disease Associated with Type 2 Diabetes: An Example Practice Model at a Health Care Practice in Kentucky, United States.Diabetes therapy : research, treatment and education of diabetes and related disorders · 2024Article
- Optimizing Multidisciplinary Care of Patients with Chronic Kidney Disease and Type 2 Diabetes Mellitus.Diabetes therapy : research, treatment and education of diabetes and related disorders · 2023Review
- "Why Didn't They Teach Us This?" A Qualitative Investigation of Pharmacist Stakeholder Perspectives of Business Management for Community Pharmacists.Pharmacy (Basel, Switzerland) · 2023Article
- Article
- Enhancing primary care capacity in chronic kidney disease management: a quality improvement educational initiative.BMJ open · 2021Article
- Development and Application of the GheOPDrugs & aging · 2018Article
- Pharmacy practice research produces findings that inform how pharmacists contribute to optimal drug therapy outcomes for Canadians.Canadian pharmacists journal : CPJ = Revue des pharmaciens du Canada : RPC · 2016Article
- The community pharmacist's role in cancer screening and prevention.Canadian pharmacists journal : CPJ = Revue des pharmaciens du Canada : RPC · 2016Review
- CPJ and CPhA: Taking evidence for pharmacist care to the next level.Canadian pharmacists journal : CPJ = Revue des pharmaciens du Canada : RPC · 2016Article
- Time to give up on expanded scope of practice.Canadian pharmacists journal : CPJ = Revue des pharmaciens du Canada : RPCArticle
- Barriers to a full scope of pharmacy practice in primary care: A systematic review of pharmacists' access to laboratory testing.Canadian pharmacists journal : CPJ = Revue des pharmaciens du Canada : RPCReview
- Community pharmacist identification of chronic kidney disease using point-of-care technology: A pilot study.Canadian pharmacists journal : CPJ = Revue des pharmaciens du Canada : RPCArticle
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
PubMed holds no abstract for this paper.
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.